6
2
↑6
↓2
—0
Evidence suggests Psilocybin mayincreaseMental health.
11 studies (8 claims)
Emerging evidence
Study Claims
| Intervention | Direction | Endpoint | Type | Population | Dosage | Title |
|---|---|---|---|---|---|---|
| psilocybin-assisted group therapy | No effect - identified as emerging intervention models | mental health | Human | sexual/gender minority (SGM) older adults living with HIV (OALWH) | Not available | The Intersection of Mental Health and Sexual and Gender Minority Identities for Older Adults Living with Human Immunodeficiency Virus: A Narrative Review.cited 1× |
| psychedelics, such as psilocybin and MDMA | No effect - offer an alternative avenue of therapy | many mental health disorders | Human | — | Not specified | The emerging role of psilocybin and MDMA in the treatment of mental illness.cited 33× |
| psychedelic substances such as psilocybin | Increases - could be used to assist in promoting | positive lifestyle change conducive to good overall health | Human | — | Not specified | Psychedelics and health behaviour change.cited 41× |
| psilocybin | Decreases - is gaining popularity as research shows potential benefits | anxiety, depression, and other mental health conditions | Human | those with anxiety, depression, and other mental health conditions | Heavy psilocybin use (specific dosage not provided). | A Case Report of Psilocybin-induced Psychosis in a Predisposed Patient. |
| Psilocybin | No effect - is a highly promising drug candidate for the treatment | depression and several other mental health conditions | Molecular | — | Not mentioned | Substrate recognition by the 4-hydroxytryptamine kinase PsiK in psilocybin biosynthesis.cited 1× |
| psilocybin | Increases - approved | mental health indications | Human | Australia | Not mentioned | Expert recommendations for Germany's integration of psychedelic-assisted therapy.cited 1× |